Role of Nano Enzyme in Diagnosis, Prognosis and Treatment of Gastrointestinal Tract (GIT) Cancer
Nano Enzymes in Diagnosis, Prognosis, and Treatment of GIT Cancer
DOI:
https://doi.org/10.69750/dmls.01.01.015Keywords:
Gastrointestinal tract cancer, Nano-enzymes, Diagnosis, prognosis, treatment, Drug delivery, Biosensors, Targeted therapy, Imaging, Biomarkers.Abstract
Background:The most common life-threatening problem in population is gastrointestinal tract (GIT) cancer and its mortality rate is very high. Now a days Nanotechnology is a modern way of diagnosis and treatment. Nano-enzymes showed best diagnosis efficacy of treatment and disease progression
Aims and objectives: The aims and objectives of current review were a comprehensive overview of Nano-enzymes in the diagnosis, prognosis, and treatment of gastrointestinal tract cancer.
Practical Implications:Through Nano-enzymes different types of cancer may be diagnosis, prognosis, and treated. While the treatment of gastrointestinal tract cancer with Nano-enzymes showed best results. In this review, we outlined the many types of nanoparticles used to treat esophageal cancer.
Conclusion:A common gastrointestinal cancer with a poor prognosis and a high fatality rate is esophageal cancer. Despite the development of multiple therapy approaches, patients with esophageal cancer still have a low 5-year survival rate. Traditional methods of delivering anti-cancer medications have some drawbacks, including no targeted administration and general toxicity. For the treatment of Esophageal cancer, nanoparticles offer a viable platform for drug delivery since they have a number of outstanding benefits, including less side effects, a longer circulation duration, and a preference for accumulating at the tumor site. These include polymers, micelles, liposomes, inorganic nanoparticles, and organic nanoparticles. In this review, we outlined the many types of nanoparticles used to treat esophageal cancer.
Downloads
References
Amin A, Amin H. Lipoprotein nanoparticles in diagnosis and treatment of cancer. MOJ Drug Des Dev Ther. 2018;2(1):15–18.
Hussain Z, Khan JA, Murtaza S. Nanotechnology: an emerging therapeutic option for breast cancer. Crit Rev Eukaryot Gene Expr. 2018;28(2):—.
Rajana N, Mounika A, Chary PS, Bhavana V, Urati A, Khatri D, et al. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer. J Control Release. 2022;352:1024–1047.
Singh RS, Singh T, Singh AK. Enzymes as diagnostic tools. In: Advances in enzyme technology. Elsevier; 2019. p. 225–271.
Abdolmaleki A, Asadi A, Gurushankar K, Shayan TK, Sarvestani FA. Importance of nanomedicine and new drug therapies for cancer. Adv Pharm Bull. 2021;11(3):450.
Vimal A, Kumar A. Transforming the healthcare system through therapeutic enzymes. In: Enzymes in food biotechnology. Elsevier; 2019. p. 603–625.
Hosseini SM, Okoye I, Chaleshtari MG, Hazhirkarzar B, Mohamadnejad J, Azizi G, et al. E2 ubiquitin-conjugating enzymes in cancer: implications for immunotherapeutic interventions. Clin Chim Acta. 2019;498:126–134.
Cao F, Jin L, Gao Y, Ding Y, Wen H, Qian Z, et al. Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis. Nat Nanotechnol. 2023:1–11.
Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, et al. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res. 2020;43:153–169.
Gupta S, Jain A, Chakraborty M, Sahni JK, Ali J, Dang S. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv. 2013;20(6):237–246.
Chivere VT, Kondiah PP, Choonara YE, Pillay V. Nanotechnology-based biopolymeric oral delivery platforms for advanced cancer treatment. Cancers. 2020;12(2):522.
Herszényi L, Barabás L, Hritz I, István G, Tulassay Z. Impact of proteolytic enzymes in colorectal cancer development and progression. World J Gastroenterol. 2014;20(37):13246.
Aggarwal V, Tuli HS, Tania M, Srivastava S, Ritzer EE, Pandey A, et al. Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement. Semin Cancer Biol. 2022.
Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res. 2006;23:1417–1450.
Wang J, Dong R, Wu H, Cai Y, Ren B. A review on artificial micro/nanomotors for cancer-targeted delivery, diagnosis, and therapy. Nano Micro Lett. 2020;12:1–19.
Sadighbayan D, Sadighbayan K, Tohid-Kia MR, Khosroushahi AY, Hasanzadeh M. Development of electrochemical biosensors for tumor marker determination towards cancer diagnosis: recent progress. TrAC Trends Anal Chem. 2019;118:73–88.
Yang M, Yang F, Chen W, Liu S, Qiu L, Chen J. Bacteria-mediated cancer therapies: opportunities and challenges. Biomater Sci. 2021;9(17):5732–5744.
Baig MH, Adil M, Khan R, Dhadi S, Ahmad K, Rabbani G, et al. Enzyme targeting strategies for prevention and treatment of cancer: implications for cancer therapy. Semin Cancer Biol. 2019.
Brakmane G, Winslet M, Seifalian A. Systematic review: the applications of nanotechnology in gastroenterology. Aliment Pharmacol Ther. 2012;36(3):213–221.
Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease. Nanomedicine. 2015;11(5):1117–1132.
Mahomoodally M, Aumeeruddy M, Rengasamy KR, Roshan S, Hammad S, Pandohee J, et al. Ginger and its active compounds in cancer therapy: from folk uses to nano-therapeutic applications. Semin Cancer Biol. 2021.
Potter C, Harris A. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer. 2003;89(1):2–7.
Wang K, Shen R, Meng T, Hu F, Yuan H. Nano-drug delivery systems based on different targeting mechanisms in the targeted therapy of colorectal cancer. Molecules. 2022;27(9):2981.
Nikolopoulos D, Theocharis S, Kouraklis G. Ghrelin’s role on gastrointestinal tract cancer. Surg Oncol. 2010;19(1):e2–e10.
Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra H, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15(4):189–197.
Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693–707.
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–648.
Herszényi L, István G, Cardin R, De Paoli M, Plebani M, Tulassay Z, et al. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Eur J Cancer Prev. 2008:438–445.
Guleria K, Singh HP, Kaur H, Sambyal V. ABO blood groups in gastrointestinal tract and breast carcinoma patients. Anthropologist. 2005;7(3):189–192.
Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020;1873(1):188314.
Cao Y, Nishihara R, Wu K, Wang M, Ogino S, Willett WC, et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA Oncol. 2016;2(6):762–769.
Jackson TC, Patani BO, Ekpa DE. Nanotechnology in diagnosis: a review. Adv Nanopart. 2017;6(3):93–102.
Feng Z, Meng H. Efficient nano-enabled therapy for gastrointestinal cancer using silicasome delivery technology. Sci China Chem. 2021;64:1946–1957.
Tinkle S, McNeil SE, Mühlebach S, Bawa R, Borchard G, Barenholz Y, et al. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci. 2014;1313(1):35–56.
Obaid G, Broekgaarden M, Bulin AL, Huang HC, Kuriakose J, Liu J, et al. Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. Nanoscale. 2016;8(25):12471–12503.
Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, et al. Diverse applications of nanomedicine. ACS Nano. 2017;11(3):2313–2381.
Sarkar S, Sarkar SC. Application of nanotechnology in medicine. Med Cal Sci. 2019;117:49.
Mukherjee S, Patra CR. Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale. 2016;8(25):12444–12470.
Zhang T, Zhu G, Lu B, Peng Q. Oral nano-delivery systems for colon targeting therapy. Pharm Nanotechnol. 2017;5(2):83–94.
Ell C, Remke S, May A, Helou L, Henrich R, Mayer G. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy. 2002;34(9):685–689.
Wanebo HJ, Kennedy B, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg. 1993;218(5):583.
Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22(11):1342–1350.
Ali ES, Sharker SM, Islam MT, Khan IN, Shaw S, Rahman MA, et al. Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives. Semin Cancer Biol. 2021.
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223.
Karimi M, Ghasemi A, Zangabad PS, Rahighi R, Basri SMM, Mirshekari H, et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev. 2016;45(5):1457–1501.
Mallakpour S, Hussain CM, Bayineni VK, Naira VR, Kadeppagari RK. Biomedical applications of nanozymes: disease diagnosis and therapy. In: Handbook of consumer nanoproducts. 2021. p. 1–13.
Bayineni VK, Naira VR, Kadeppagari RK. Biomedical applications of nanozymes: disease diagnosis and therapy. In: Handbook of consumer nanoproducts. Springer; 2022. p. 675–687.
Su Z, Du T, Liang X, Wang X, Zhao L, Wang J, et al. Nanozymes for foodborne microbial contaminants detection: mechanisms, recent advances, and challenges. Food Control. 2022:109165.
Niu X, Cheng N, Ruan X, Du D, Lin Y. Nanozyme-based immunosensors and immunoassays: recent developments and future trends. J Electrochem Soc. 2020;167(3):037508.
Wang P, Wang T, Hong J, Yan X, Liang M. Nanozymes: a new disease imaging strategy. Front Bioeng Biotechnol. 2020;8:15.
Thorn CR, Howell PL, Wozniak DJ, Prestidge CA, Thomas N. Enhancing the therapeutic use of biofilm-dispersing enzymes with smart drug delivery systems. Adv Drug Deliv Rev. 2021;179:113916.
Munir S, Shah AA, Rahman H, Bilal M, Rajoka MSR, Khan AA, et al. Nanozymes for medical biotechnology and its potential applications in biosensing and nanotherapeutics. Biotechnol Lett. 2020;42:357–373.
Xie B, Yang X, Zhang R, Guo J, Chen Z, He Y. Hollow and porous Fe3C-NC nanoballoons nanozymes for cancer cell H₂O₂ detection. Sens Actuators B Chem. 2021;347:130597.
Prados J, Melguizo C, Perazzoli G, Cabeza L, Carrasco E, Oliver J, et al. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents. Recent Pat Anticancer Drug Discov. 2014;9(1):21–34.
Chadar R, Kesharwani P. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer. Int J Pharm. 2021;605:120835.
Banerjee A, Pathak S, Subramanium VD, Dharanivasan G, Murugesan R, Verma RS. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug Discov Today. 2017;22(8):1224–1232.
Laroui H, Rakhya P, Xiao B, Viennois E, Merlin D. Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders. Dig Liver Dis. 2013;45(12):995–1002.
Bhatnagar P, Patnaik S, Srivastava AK, Mudiam MK, Shukla Y, Panda AK, et al. Anti-cancer activity of bromelain nanoparticles by oral administration. J Biomed Nanotechnol. 2014;10(12):3558–3575.
Rath G, Goyal AK. Introduction to nanotechnology.
Liang M, Li LD, Li L, Li S. Nanotechnology in diagnosis and therapy of gastrointestinal cancer. World J Clin Cases. 2022;10(16):5146.
Poellmann MJ, Bu J, Liu S, Wang AZ, Seyedin SN, Chandrasekharan C, et al. Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosens Bioelectron. 2023;226:115117.
Sun B, Fang Y, Li Z, Chen Z, Xiang J. Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors. Mol Clin Oncol. 2015;3(2):274–280.
Sakamoto JH, van de Ven AL, Godin B, Blanco E, Serda RE, Grattoni A, et al. Enabling individualized therapy through nanotechnology. Pharmacol Res. 2010;62(2):57–89.
Ringel VM, Allen IC. The role of nanotechnology in detection and treatment in gastrointestinal cancers. In: Elucidating the role of pattern recognition receptors in understanding, treating, and targeting cancer. 2019. p. 183.
Surendiran A, Sandhiya S, Pradhan S, Adithan C. Novel applications of nanotechnology in medicine. Indian J Med Res. 2009;130(6):689–701.
Sykes PD, Neoptolemos JP, Costello E, Halloran CM. Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Expert Rev Gastroenterol Hepatol. 2012;6(3):343–356.
Bollschweiler E, Boettcher K, Hoelscher AH, Siewert JR, Sasako M, Kinoshita T, et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer. 1993;71(10):2918–2925.
Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228(4):449.
Allum W, Powell D, McConkey C, Fielding J. Gastric cancer: a 25-year review. Br J Surg. 1989;76(6):535–540.
Meyer HJ, Wilke H. Treatment strategies in gastric cancer. Dtsch Arztebl Int. 2011;108(41):698.
Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626.
Layke JC, Lopez PP. Gastric cancer: diagnosis and treatment options. Am Fam Physician. 2004;69(5):1133–1140.
Dassen A, Lemmens V, Van de Poll-Franse L, Creemers GJ, Brenninkmeijer S, Lips D, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010;46(6):1101–1109.
Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer H. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg. 1993;80(8):1015–1018.
Kumar B, Murali A, Bharath A, Giri S. Guar gum modified upconversion nanocomposites for colorectal cancer treatment through enzyme-responsive drug release and NIR-triggered photodynamic therapy. Nanotechnology. 2019;30(31):315102.
Shanmugam H, Rengarajan C, Nataraj S, Sharma A. Interactions of plant food bioactives-loaded nano delivery systems at the nano-bio interface and its pharmacokinetics: an overview. Food Front. 2022;3(2):256–275.
Zhang T, Zhu G, Lu B, Qian Z, Peng Q. Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles. Med Res Rev. 2021;41(3):1835–1850.
Deng S, Gu J, Jiang Z, Cao Y, Mao F, Xue Y, et al. Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer. J Nanobiotechnol. 2022;20(1):415.
Lou X, Chen Z, He Z, Sun M, Sun J. Bacteria-mediated synergistic cancer therapy: small microbiome has a big hope. Nano Micro Lett. 2021;13:1–26.
Mei L, Zhang Z, Zhao L, Huang L, Yang XL, Tang J, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65(6):880–890.
Tan YY, Yap PK, Lim GLX, Mehta M, Chan Y, Ng SW, et al. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. Chem Biol Interact. 2020;329:109221.
Rahman MM, Islam MR, Akash S, Harun-Or-Rashid M, Ray TK, Rahaman MS, et al. Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: at a glance. Biomed Pharmacother. 2022;153:113305.
Liu Y, Ding X, Li J, Luo Z, Hu Y, Liu J, et al. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo. Nanotechnology. 2015;26(14):145102.
Nurunnabi M, Revuri V, Huh KM, Lee YK. Polysaccharide-based nano/microformulation: an effective and versatile oral drug delivery system. In: Nanostructures for oral medicine. Elsevier; 2017. p. 409–433.
Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, et al. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm. 2021;600:120461.
Vieira IRS, Conte-Junior CA. Nano-delivery systems for food bioactive compounds in cancer: prevention, therapy, and clinical applications. Crit Rev Food Sci Nutr. 2022:1–26.
Barani M, Rahdar A, Sargazi S, Amiri MS, Sharma PK, Bhalla N. Nanotechnology for inflammatory bowel disease management: detection, imaging and treatment. Sens Biosensing Res. 2021;32:100417.
Fan JX, Li ZH, Liu XH, Zheng DW, Chen Y, Zhang XZ. Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-α expression via oral administration. Nano Lett. 2018;18(4):2373–2380.
Alam MAU, Khatun M, Alam MAU. Recent trend of nanotechnology applications to improve bio-accessibility of lycopene by nanocarrier: a review. arXiv. 2023.
He H, Du L, Xue H, An Y, Zeng K, Huang H, et al. Triple tumor microenvironment-responsive ferroptosis pathways induced by manganese-based imageable nanoenzymes for enhanced breast cancer theranostics. Small Methods. 2023:2300230.
Li W, Liu D, Zhang H, Correia A, Mäkilä E, Salonen J, et al. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy. Acta Biomater. 2017;48:238–246.
Xu C, Ban Q, Wang W, Hou J, Jiang Z. Novel nano-encapsulated probiotic agents: encapsulate materials, delivery, and encapsulation systems. J Control Release. 2022;349:184–205.
Satapathy S, Patro CS. Solid lipid nanoparticles for efficient oral delivery of tyrosine kinase inhibitors: a nano-targeted cancer drug delivery. Adv Pharm Bull. 2021;12(2):298–308.
Khan H, Ullah H, Martorell M, Valdes SE, Belwal T, Tejada S, et al. Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects. Semin Cancer Biol. 2021.
Huang J, Shu Q, Wang L, Wu H, Wang AY, Mao H. Layer-by-layer assembled milk protein-coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. Biomaterials. 2015;39:105–113.
Choi H, Cho SH, Hahn SK. Urease-powered polydopamine nanomotors for intravesical therapy of bladder diseases. ACS Nano. 2020;14(6):6683–6692.
Zhang J, Chen Z, Kankala RK, Wang SB, Chen AZ. Self-propelling micro/nano-motors: mechanisms, applications, and challenges in drug delivery. Int J Pharm. 2021;596:120275.
Kumar B, Kulanthaivel S, Mondal A, Mishra S, Banerjee B, Bhaumik A, et al. Mesoporous silica nanoparticle-based enzyme responsive system for colon-specific drug delivery through guar gum capping. Colloids Surf B Biointerfaces. 2017;150:352–361.
Ma X, Feng H, Liang C, Liu X, Zeng F, Wang Y. Mesoporous silica as micro/nano-carrier: from passive to active cargo delivery, a mini review. J Mater Sci Technol. 2017;33(10):1067–1074.
Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation II: biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine. 2006;2(2):53–65.
Zhang S, Langer R, Traverso G. Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease. Nano Today. 2017;16:82–96.
Emeje MO, Obidike IC, Akpabio EI, Ofoefule SI. Nanotechnology in drug delivery. Recent Adv Novel Drug Carrier Syst. 2012;1(4):69–106.
Lu Y, Luo Q, Jia X, Tam JP, Yang H, Shen Y, et al. Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii folium: integration of herbal medicine, enzyme engineering, and nanotechnology. J Pharm Anal. 2022.
Song Q, Jia J, Niu X, Zheng C, Zhao H, Sun L, et al. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy. Nanoscale. 2019;11(34):15958–15970.
Shah BM, Palakurthi SS, Khare T, Khare S, Palakurthi S. Natural proteins and polysaccharides in the development of micro/nano delivery systems for the treatment of inflammatory bowel disease. Int J Biol Macromol. 2020;165:722–737.
Meng X, Li D, Chen L, He H, Wang Q, Hong C, et al. High-performance self-cascade pyrite nanozymes for apoptosis–ferroptosis synergistic tumor therapy. ACS Nano. 2021;15(3):5735–5751.
Salapa J, Bushman A, Lowe K, Irudayaraj J. Nano drug delivery systems in upper gastrointestinal cancer therapy. Nano Converg. 2020;7(1):1–17.
Singh AV, Ansari MHD, Laux P, Luch A. Micro-nanorobots: important considerations when developing novel drug delivery platforms. Expert Opin Drug Deliv. 2019;16(11):1259–1275.
Cafarelli A, Marino A, Vannozzi L, Puigmartí-Luis J, Pané S, Ciofani G, et al. Piezoelectric nanomaterials activated by ultrasound: the pathway from discovery to future clinical adoption. ACS Nano. 2021;15(7):11066–11086.
Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic point-of-care diagnostic devices. Lab Chip. 2013;13(12):2210–2251.
Ferrari AC, Bonaccorso F, Fal’Ko V, Novoselov KS, Roche S, Bøggild P, et al. Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale. 2015;7(11):4598–4810.
Nair M, Jayant RD, Kaushik A, Sagar V. Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev. 2016;103:202–217.
Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, et al. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Phys Med Biol. 2020;65(21):21RM02.
Lou-Franco J, Das B, Elliott C, Cao C. Gold nanozymes: from concept to biomedical applications. Nano Micro Lett. 2021;13:1–36.
Su L, Qin S, Xie Z, Wang L, Khan K, Tareen AK, et al. Multi-enzyme activity nanozymes for biosensing and disease treatment. Coord Chem Rev. 2022;473:214784.
Chen L, Huang Q, Zhao T, Sui L, Wang S, Xiao Z, et al. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: new insight for treating COVID-19. Redox Biol. 2021;45:102046.
Sheng J, Wu Y, Ding H, Feng K, Shen Y, Zhang Y, et al. Multienzyme-like nanozymes: regulation, rational design, and application. Adv Mater. 2023:2211210.
Mou X, Wu Q, Zhang Z, Liu Y, Zhang J, Zhang C, et al. Nanozymes for regenerative medicine. Small Methods. 2022;6(11):2200997.
Liu D, Ju C, Han C, Shi R, Chen X, Duan D, et al. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen. Biosens Bioelectron. 2021;173:112817.
Kaya SI, Ozcelikay G, Mollarasouli F, Bakirhan NK, Ozkan SA. Recent achievements and challenges on nanomaterial-based electrochemical biosensors for the detection of colon and lung cancer biomarkers. Sens Actuators B Chem. 2022;351:130856.
Bohunicky B, Mousa SA. Biosensors: the new wave in cancer diagnosis. Nanotechnol Sci Appl. 2010:1–10.
Didamson OC, Abrahamse H. Targeted photodynamic diagnosis and therapy for esophageal cancer: potential role of functionalized nanomedicine. Pharmaceutics. 2021;13(11):1943.
Downloads
PlumX Metrics
Published
Issue
Section
License
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you must obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
How to Cite
